DiscoverMyFSHDOur take on Avidity's FORTITUDE phase 1/2 trial data
Our take on Avidity's FORTITUDE phase 1/2 trial data

Our take on Avidity's FORTITUDE phase 1/2 trial data

Update: 2025-06-11
Share

Description

"I'll have what she's having." We'll take you through and discuss the recent release of Avidity Biosciences topline results from the phase 1/2 FORTITUDE trial and the preliminary data from the biomarker cohort extension.

Comments 
In Channel
Friends and funding.

Friends and funding.

2025-02-2301:34:06

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Our take on Avidity's FORTITUDE phase 1/2 trial data

Our take on Avidity's FORTITUDE phase 1/2 trial data

Peter L Jones, PhD